Pharmaceutical Regulation and Incentives for Innovation in an International Perspective

Pierre Dubois

Working Papers from HAL

Abstract: We examine pharmaceutical regulations and incentives for innovation from an international perspective, highlighting the public good nature of healthcare innovation and its cross-border diffusion. We summarize the empirical evidence on how push and pull incentives shape R&D investment, innovation, and global access. We emphasize the role of strategic interdependencies and spillovers, including free-riding in R&D financing, learning-by-doing effects, drug shortages, reference pricing, and parallel trade. We then provide new evidence on the international spillovers of pull incentives on innovation, showing that international cooperation and innovative institutions are necessary to better align national regulations with the global objective of sustaining pharmaceutical innovation.

Keywords: R&D; International Spillovers; Innovation; Pharmaceutical Regulation (search for similar items in EconPapers)
Date: 2025-10-13
Note: View the original document on HAL open archive server: https://hal.science/hal-05310888v1
References: Add references at CitEc
Citations:

Downloads: (external link)
https://hal.science/hal-05310888v1/document (application/pdf)

Related works:
Working Paper: Pharmaceutical Regulation and Incentives for Innovation in an International Perspective (2025)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:wpaper:hal-05310888

Access Statistics for this paper

More papers in Working Papers from HAL
Bibliographic data for series maintained by CCSD ().